GHUCCTS

News

Share This
  • May 01, 2020

NIH awards $24M to GHUCCTS to support clinical and translational research

WASHINGTON (May 1, 2020) - The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) has received a $24.3 million Clinical and Translational Science Award from the National Center for Advancing Translational Science, a part of the National Institutes of Health.

The competitive renewal represents the third 5-year award for the center, which has secured $89.8 million in research funding over 15-years for its member institutions: Georgetown University, Howard University, MedStar Health Research Institute, the Washington DC Veterans Affairs Medical Center and Oak Ridge National Laboratory.

Led by principal investigators Joseph Verbalis, MD, from Georgetown University and Thomas Mellman, MD, from Howard University, the mission of GHUCCTS is to advance research and training with excellence, innovation, collaboration, and efficiency while realizing the potential of the unique capacities of its constituent institutions for developing new technologies, promoting ethical clinical and translational research, and engaging the diverse populations of our communities that have been historically underrepresented in clinical research, including people from diverse racial, ethnic, and cultural backgrounds, people with disabilities, and older adults.

“One of the major missions of GHUCCTS has been to stimulate and support the growth of team science,” says Verbalis, a professor of medicine at Georgetown. “Advances in solving the complex and challenging health problems we face today can be achieved more quickly and efficiently by collaborations among investigators from different scientific disciplines working together on common problems.”

“GHUCCTS was built on a unique model of co-leadership between Georgetown and Howard University, a Historically Black University,” says Mellman, a professor of psychiatry at Howard. “The partnership has influenced prioritizing health disparities and diversity in our training and research missions. Diversity of institutional cultures and of the disciplines represented in our programs has been a founding and enduring strength of GHUCCTS.” 

As one of 60 national CTSA programs, GHUCCTS has transformed research in the greater Washington DC region. Verbalis and Mellman along with faculty members from all of the GHUCCTS institutions and numerous collaborators across the region have achieved impressive goals over the last 10 years, including:

With this new award, GHUCCTS will continue to develop and promote innovative clinical and translational science research to improve the health of the greater Washington DC population.

Download PDF

Related News

GHUCCTS member Florencia Gonzalez speaks on recent NHCOA panel "Lessons from the Field: Conducting Health Research with Hard to Reach Populations"

Oct 01, 2020

For the last two years, the National Hispanic Council on Aging (NHCOA) has partnered with the National Institutes of Health to raise awareness about the All of Us Research Program (AoU). The All of Us Research Program is inviting one million people across the U.S. to help build one of the most diverse health databases in history. NHCOA’s role in the AoU program is to raise awareness about health research and the program itself. In an effort to do that, we are hosting a webinar entitled, “Lessons from the Field: Conducting health research with hard to reach populations.” This webinar provided a space for researchers and other AoU partners to learn from community researchers who already engage hard to reach populations.

ACTS now accepting session proposals and abstracts for TS21

Oct 01, 2020

The Association for Clinical and Translational Science (ACTS) is now accepting session proposals and abstracts for Translational Science 2021.

CLIC announces funding opportunity for COVID-19 Synergy Papers

Sep 30, 2020

The SARS-COV-2 or COVID-19 pandemic has significantly affected the world we live in both personally and professionally. This rapid response Synergy Paper application will provide teams the opportunity to apply to and receive support for a manuscript focusing on novel research approaches in translational research implemented as a result of the pandemic.

Close